150 related articles for article (PubMed ID: 16610021)
1. Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: Our experience with a prospective study.
Giampaolo B; Giuseppe P; Michele B; Alessandro M; Fabrizio S; Alfonso C
World J Gastroenterol; 2006 Apr; 12(14):2201-4. PubMed ID: 16610021
[TBL] [Abstract][Full Text] [Related]
2. Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study.
Sacco R; Romano A; Mazzoni A; Bertini M; Federici G; Metrangolo S; Parisi G; Nencini C; Giampietro C; Bertoni M; Tumino E; Scatena F; Bresci G
J Crohns Colitis; 2013 Dec; 7(12):e692-7. PubMed ID: 23870727
[TBL] [Abstract][Full Text] [Related]
3. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis.
Naganuma M; Funakoshi S; Sakuraba A; Takagi H; Inoue N; Ogata H; Iwao Y; Ishi H; Hibi T
Inflamm Bowel Dis; 2004 May; 10(3):251-7. PubMed ID: 15290920
[TBL] [Abstract][Full Text] [Related]
4. [Granulocytapheresis in inflammatory bowel disease. Efficacy of an induction plus maintenance sessions protocol at 32 weeks].
Fernández Pérez FJ; Rodríguez F; de Sola C; Fernández Moreno N; Vera F; Rivera R; Sánchez Cantos A
Rev Esp Enferm Dig; 2007 Nov; 99(11):628-35. PubMed ID: 18271660
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
6. Adsorptive Monocyte-granulocytapheresis (M-GCAP) for refractory Crohn's disease.
Kusaka T; Fukunaga K; Ohnishi K; Kosaka T; Tomita T; Yokoyama Y; Sawada K; Fukuda Y; Miwa H; Matsumoto T
J Clin Apher; 2004; 19(4):168-73. PubMed ID: 15597346
[TBL] [Abstract][Full Text] [Related]
7. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
Suzuki Y; Yoshimura N; Fukuda K; Shirai K; Saito Y; Saniabadi AR
Dig Dis Sci; 2006 Nov; 51(11):2031-8. PubMed ID: 17004123
[TBL] [Abstract][Full Text] [Related]
8. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study.
Suzuki Y; Yoshimura N; Saniabadi AR; Saito Y
Dig Dis Sci; 2004 Apr; 49(4):565-71. PubMed ID: 15185858
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia.
Ljung T; Thomsen OØ; Vatn M; Karlén P; Karlsen LN; Tysk C; Nilsson SU; Kilander A; Gillberg R; Grip O; Lindgren S; Befrits R; Löfberg R
Scand J Gastroenterol; 2007 Feb; 42(2):221-7. PubMed ID: 17327942
[TBL] [Abstract][Full Text] [Related]
10. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis.
Tomomasa T; Kobayashi A; Kaneko H; Mika S; Maisawa S; Chino Y; Syou H; Yoden A; Fujino J; Tanikawa M; Yamashita T; Kimura S; Kanoh M; Sawada K; Morikawa A
Dig Dis Sci; 2003 Apr; 48(4):750-4. PubMed ID: 12741466
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
Kanke K; Nakano M; Hiraishi H; Terano A
Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
[TBL] [Abstract][Full Text] [Related]
13. [Granulocyte and monocyte adsorption apheresis in Korean conventional treatment-refractory patients with active ulcerative colitis: a prospective open-label multicenter study].
Kim HJ; Kim JS; Han DS; Yang SK; Hahm KB; Lee WI; Kwon SW; Choi JH; Kim WH; Choi KY; Song IS
Korean J Gastroenterol; 2005 Jan; 45(1):34-44. PubMed ID: 15665566
[TBL] [Abstract][Full Text] [Related]
14. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
Passalacqua S; Ferraro PM; Bresci G; D'Ovidio V; Astegiano M; Principi M; Testa R; D'Incà R; Valpiani D; Armuzzi A; Sablich R; Cavallaro F; Costa F; Di Leo V; Colombo E; Santini A; Aratari A; Lecis P; Saladino V; Riegler G; Marco M; Calella F; Ricci C; Guidi ML; Repaci G; Silla M
J Clin Apher; 2011 Dec; 26(6):332-7. PubMed ID: 22072543
[TBL] [Abstract][Full Text] [Related]
15. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study.
Fukuda Y; Matsui T; Suzuki Y; Kanke K; Matsumoto T; Takazoe M; Matsumoto T; Motoya S; Honma T; Sawada K; Yao T; Shimoyama T; Hibi T
J Gastroenterol; 2004 Dec; 39(12):1158-64. PubMed ID: 15622479
[TBL] [Abstract][Full Text] [Related]
16. Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.
Sands BE; Sandborn WJ; Wolf DC; Katz S; Safdi M; Schwartz DA; Hanauer SB
J Clin Gastroenterol; 2006 Jul; 40(6):482-9. PubMed ID: 16825929
[TBL] [Abstract][Full Text] [Related]
17. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
18. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
Domènech E; Hinojosa J; Esteve-Comas M; Gomollón F; Herrera JM; Bastida G; Obrador A; Ruiz R; Saro C; Gassull MA;
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1347-52. PubMed ID: 15606397
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.
Dignass A; Akbar A; Baumgart DC; Bommelaer G; Bouguen G; Cadiot G; Gillessen A; Grimaud JC; Hart A; Hoque S; Makins R; Michiels C; Moreau J; Premchand P; Ramlow W; Schanz S; Subramanian S; von Tirpitz C; Bonaz B
Scand J Gastroenterol; 2018 Apr; 53(4):442-448. PubMed ID: 29513111
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study.
Hanai H; Watanabe F; Takeuchi K; Iida T; Yamada M; Iwaoka Y; Saniabadi A; Matsushita I; Sato Y; Tozawa K; Arai H; Furuta T; Sugimoto K; Bjarnason I
Clin Gastroenterol Hepatol; 2003 Jan; 1(1):28-35. PubMed ID: 15017514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
